DE602006009641D1 - Komplementäre zusammensetzungen zur verringerung der blutzuckerspiegel und zur behandlung von diabetes - Google Patents

Komplementäre zusammensetzungen zur verringerung der blutzuckerspiegel und zur behandlung von diabetes

Info

Publication number
DE602006009641D1
DE602006009641D1 DE602006009641T DE602006009641T DE602006009641D1 DE 602006009641 D1 DE602006009641 D1 DE 602006009641D1 DE 602006009641 T DE602006009641 T DE 602006009641T DE 602006009641 T DE602006009641 T DE 602006009641T DE 602006009641 D1 DE602006009641 D1 DE 602006009641D1
Authority
DE
Germany
Prior art keywords
mirrors
composition
blood sugar
reducing blood
treating diabetes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006009641T
Other languages
English (en)
Inventor
Eric Hayes
Alexander Zolotoy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astrum Therapeutics Pty Ltd
Original Assignee
Astrum Therapeutics Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrum Therapeutics Pty Ltd filed Critical Astrum Therapeutics Pty Ltd
Publication of DE602006009641D1 publication Critical patent/DE602006009641D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE602006009641T 2005-04-07 2006-04-07 Komplementäre zusammensetzungen zur verringerung der blutzuckerspiegel und zur behandlung von diabetes Active DE602006009641D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66968205P 2005-04-07 2005-04-07
PCT/US2006/012903 WO2006110491A2 (en) 2005-04-07 2006-04-07 Complementary compositions to reduce blood glucose levels and treat diabetes

Publications (1)

Publication Number Publication Date
DE602006009641D1 true DE602006009641D1 (de) 2009-11-19

Family

ID=36999982

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006009641T Active DE602006009641D1 (de) 2005-04-07 2006-04-07 Komplementäre zusammensetzungen zur verringerung der blutzuckerspiegel und zur behandlung von diabetes

Country Status (6)

Country Link
US (1) US7687082B2 (de)
EP (1) EP1874285B1 (de)
AT (1) ATE444744T1 (de)
AU (1) AU2006235123A1 (de)
DE (1) DE602006009641D1 (de)
WO (1) WO2006110491A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2643299A1 (en) * 2006-02-21 2007-08-30 Astrum Therapeutics Pty. Ltd. Compositions to reduce blood glucose levels and treat diabetes
US8652550B2 (en) 2008-01-16 2014-02-18 Hydro One, Llc Health beverages comprising cinnamon extract and methods of making and using the same
CA2642184A1 (en) * 2008-10-28 2010-04-28 Goliath Oil And Gas Corporation Composition containing ginseng and cinnamon
US9918489B2 (en) 2008-12-17 2018-03-20 Mark Gorris Food-based supplement delivery system
US20100178413A1 (en) * 2008-12-17 2010-07-15 Mark Gorris Food-based Supplement Delivery System
ES2395529B1 (es) 2011-06-08 2014-04-11 Pri, S.A. Combinación sinérgica para el tratamiento de la diabetes mellitus tipo 2.
CN102526198A (zh) * 2012-03-14 2012-07-04 南昌大学 一种以肉桂和铬为添加剂的药品及保健品的制备方法
CN103436582B (zh) * 2013-07-10 2015-12-23 马杰坤 一种魔芋多肽提取物、制备方法及其用途
GB201319525D0 (en) * 2013-11-05 2013-12-18 Optibiotix Health Ltd Composition

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08127538A (ja) * 1994-10-31 1996-05-21 Masakiyo Takahashi 糖尿病治療薬
US5962030A (en) 1997-03-07 1999-10-05 Akesis Pharmaceuticals, Inc. Dietary supplement and method of treatment for diabetic control
US6376549B1 (en) * 1998-09-17 2002-04-23 Akesis Pharmaceuticals, Inc. Metforimin-containing compositions for the treatment of diabetes
AU4031500A (en) * 1999-03-26 2000-10-16 Akesis Pharmaceuticals, Inc. Edible solids for treatment of glucose metabolism disorders
US6562836B1 (en) 1999-05-24 2003-05-13 Queen's University Of Kingston Methods and compounds for inhibiting amyloid deposits
US6207714B1 (en) * 1999-09-14 2001-03-27 Dallas L. Clouatre Methods and pharmaceutical preparations for improving glucose metabolism with (−)-hydroxycitric acid
US7326404B2 (en) * 2000-05-31 2008-02-05 Vuksan Holdings Inc. Konjac-mannan and ginseng compositions and methods and uses thereof
CA2310513A1 (en) * 2000-05-31 2001-11-30 Vladimir Vuksan Compositions and methods for reducing blood glucose
US20020098247A1 (en) * 2000-11-02 2002-07-25 Komorowski James R. Methods and compositions for the improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes and alpha lipoic acid
TWI329516B (en) * 2000-12-12 2010-09-01 Kaneka Corp Composition for preventing or ameliorating multiple risk factor syndromes and visceral fat-type obesity
US20020147153A1 (en) * 2001-02-14 2002-10-10 Functional Foods, Inc. Nutritional supplement to alleviate symptoms associated with reduced levels of serotonin
US6849613B2 (en) * 2001-08-29 2005-02-01 Kedar N. Prasad Multiple antioxidant micronutrients
ES2386782T3 (es) 2002-03-08 2012-08-30 Philera New Zealand Limited Prevención y/o tratamiento de la enfermedad cardiovascular y/o la insuficiencia cardíaca asociada
US6787163B2 (en) 2003-01-21 2004-09-07 Dennis H. Harris Therapeutic treatment for blood sugar regulation
CN1302712C (zh) * 2005-11-08 2007-03-07 南京中脉科技发展有限公司 一种减肥饼干及其制备方法

Also Published As

Publication number Publication date
US20060251736A1 (en) 2006-11-09
US7687082B2 (en) 2010-03-30
EP1874285B1 (de) 2009-10-07
WO2006110491A3 (en) 2007-04-05
EP1874285A2 (de) 2008-01-09
ATE444744T1 (de) 2009-10-15
AU2006235123A1 (en) 2006-10-19
WO2006110491B1 (en) 2007-05-31
WO2006110491A2 (en) 2006-10-19

Similar Documents

Publication Publication Date Title
DE602006009641D1 (de) Komplementäre zusammensetzungen zur verringerung der blutzuckerspiegel und zur behandlung von diabetes
WO2007002836A3 (en) Methods and compositions for the prevention and treatment of kidney disease
DE602007006641D1 (de) Zusammensetzungen zur verringerung des blutglukosespiegels und zur behandlung von diabetes
EA201300522A1 (ru) Фармацевтические комбинации для лечения метаболических нарушений
EA200900940A1 (ru) Фармацевтическая композиция, содержащая пиразол-о-глюкозидное производное
NO20064584L (no) Tetrahydropyridoindolderivater
EA201100266A1 (ru) Диокса-бицикло[3.2.1]октан-2,3,4-триольные производные
EA200501936A1 (ru) Производные пиридо[2,1-a]изохинолина в качестве ингибиторов dpp-iv
EA201000515A1 (ru) Активаторы глюкокиназы
WO2007002572A3 (en) Nattokinase for reducing whole blood viscosity
WO2007127273A3 (en) Methods and compositions for altering cell function
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
WO2005113016A3 (en) Modulation of glucose-6-phosphatase translocase expression
MX2007007174A (es) Derivados de cicloalquilamina.
WO2006012642A3 (en) Pyrrole derivatives as pharmaceutical agents
WO2005023083A3 (en) Compositions and methods for the treatment of severe acute respiratory syndrome (sars)
WO2006105440A3 (en) Nicotinamide riboside and analogues thereof
GEP20125565B (en) Lactam compounds and their pharmaceutical use
TW200738246A (en) Methods for preventing and treating metabolic disorders and new pyrazole-O-glycoside derivatives
WO2007128817A3 (en) Insulin derivative
TW200604193A (en) Substituted oxazole-benzoisothiazole dioxide derivatives, process for their preparation and their use
NO20072608L (no) Biaryloksymetylarenkarboksylsyrer
WO2008108958A3 (en) Benzimidazole derivatives and methods of use thereof
MX2009009417A (es) Piperidinil-piperidina y piperazinil-piperidina para uso en el tratamiento de diabetes o dolor.
EA201200968A1 (ru) Применение транс-кломифена для предотвращения или лечения диабета 2 типа у мужчин

Legal Events

Date Code Title Description
8364 No opposition during term of opposition